Ligand · X8S
X8S · (tert-butyl {1-[(3-oxo-3-{[(pyridin-3-yl-kappan) methyl]amino}propyl)sulfanyl]-3-phenylpropan-2-yl}carbamate)(6,6'-dimethyl-2,2'-bipyridine-kappa~2~n~1~,n~1'~)(1~2~,2~2~:2~6~,3~2~-terpyridine-kappa~3~n~1^{1~},n~2^{1~},n~3^{1~})ruthenium
X8S, (tert-butyl {1-[(3-oxo-3-{[(pyridin-3-yl-kappan) methyl]amino}propyl)sulfanyl]-3-phenylpropan-2-yl}carbamate)(6,6'-dimethyl-2,2'-bipyridine-kappa~2~n~1~,n~1'~)(1~2~,2~2~:2~6~,3~2~-terpyridine-kappa~3~n~1^{1~},n~2^{1~},n~3^{1~})rutheniu…
- Component
- X8S
- Formula
- C50 H54 N8 O3 Ru S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
X8S in 2 structures; the first of them:
- 7KS8 · Crystal structure of human CYP3A4 with the caged inhibitor · X8S A603 · binds PHE57, ARG105, ARG106, PRO107, PHE108, SER119, ILE120, PHE215 and 13 more
- 7KS8 · Crystal structure of human CYP3A4 with the caged inhibitor · X8S A603 · binds PHE57, ARG105, ARG106, PRO107, PHE108, SER119, ILE120, PHE215 and 13 more
Residues it binds most
PHE 2, ARG 2, ILE 2, ALA 2, ASP 2, GLU 2, GLY 2, LEU 2, MET 2, PRO 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.